SUPG Phase II NHL data

SuperGen (SUPG) said data from 40 of 55 low-grade non-Hodgkin's lymphoma (NHL) patients in an ongoing Phase II trial showed that SUPG's Nipent pentostatin in combination with Rituxan rituximab from Id...